Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr 28;139(17):2581-2583.
doi: 10.1182/blood.2022016118.

Second-dose VITT: rare but real

Affiliations
Editorial

Second-dose VITT: rare but real

Sue Pavord et al. Blood. .
No abstract available

PubMed Disclaimer

Figures

None
Overview of VITT. Professional illustration by Somersault18:24.

Comment on

References

    1. Krzywicka K, van de Munckhof A, Zimmerman J, et al. Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose. Blood. 2022;139(17):2720–2724. - PMC - PubMed
    1. Pavord S, Scully M, Hunt BJ, et al. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med. 2021;385(18):1680–1689. - PMC - PubMed
    1. Makris M, Pavord S. Most cases of thrombosis and thrombocytopenia syndrome (TTS) post ChAdOx-1 nCoV-19 are vaccine-induced immune thrombotic thrombocytopenia (VITT) Lancet Reg Health Eur. 2021;12:100274. - PMC - PubMed
    1. Bhuyan P, Medin J, da Silva HG, et al. Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis. Lancet. 2021;398(10300):577–578. - PMC - PubMed
    1. Pavord S, Scully M, Lester W, Makris M, Hunt BJ. Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? Lancet. 2021;398(10313):1801–1802. - PubMed